Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-20 MARCUS JOEL S Director Sale −5,000 $18.76 $94K 324,700
2020-05-19 MARCUS JOEL S Director Sale −7,809 $18.40 $144K 329,700
2020-05-18 MARCUS JOEL S Director Sale −15,000 $19.15 $287K 337,509
2020-05-08 Lucchino David L. President and CEO Sale −10,478 $18.18 $190K 433,800
2020-05-06 Loose Christopher R. Chief Scientific Officer Sale −3,946 $16.23 $64K 192,336
2020-05-06 Loose Christopher R. Chief Scientific Officer Sale −554 $16.68 $9K 191,782
2020-05-05 Lucchino David L. President and CEO Sale −5,239 $16.19 $85K 444,278
2020-05-01 Lucchino David L. President and CEO Sale −5,236 $15.28 $80K 449,517
2020-04-24 Lucchino David L. President and CEO Sale −729 $16.35 $12K 454,753
2020-04-23 Lucchino David L. President and CEO Sale −1,410 $16.08 $23K 455,482
2020-04-22 Loose Christopher R. Chief Scientific Officer Sale −4,500 $14.84 $67K 196,282
2020-04-17 Lucchino David L. President and CEO Sale −3,100 $16.00 $50K 456,892
2020-04-15 Lucchino David L. President and CEO Sale −5,236 $15.13 $79K 459,992
2020-04-08 Loose Christopher R. Chief Scientific Officer Sale −4,500 $14.99 $67K 200,782
2020-02-12 Arnold Wendy S Chief People Officer Grant or award · Stock Option +130,000 130,000
2020-02-12 Mitrano Richard J. VP Finance & Operations Grant or award · Stock Option +18,000 18,000
2020-02-12 Loose Christopher R. Chief Scientific Officer Grant or award · Stock Option +57,500 57,500
2020-02-12 Hilt Dana Charles Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2020-02-12 Lucchino David L. President and CEO Grant or award · Stock Option +242,500 242,500
2020-02-12 LeBel Carl Chief Development Officer Grant or award · Stock Option +57,500 57,500

Page 31 of 34 · 670 trades